Store

Home | Store | In Vitro Diagnostic (IVD) Trends and Market Update, 2025

In Vitro Diagnostic (IVD) Trends and Market Update, 2025

Publication Date: April 8, 2025

SKU: 25-046KA

Tags: Coagulation, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Patient Monitoring and Telehealth, Point-of-Care (POC) Testing

Pages: 50

SKU: 25-046KA

X

Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 provides the latest insights into the dynamic IVD market amid ongoing economic and global uncertainties. Published twice a year—first in April 2025 and again in Q4 2025, following the release of Kalorama’s annual 1,600-page study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves both as a standalone resource and a companion to Kalorama’s annual flagship IVD analysis. 

In 2024, the IVD market continued to expand, with most segments experiencing growth, despite the decline in COVID-19 testing revenues. AI-driven innovations, regulatory shifts, and changes in global healthcare spending are shaping the competitive landscape, reinforcing the resilience of the IVD sector. 

Key growth areas attracting industry attention and that are anticipated to play a significant role in the future of IVD include: 

  • Point-of-care diabetes testing 
  • Companion diagnostics technologies 
  • Immunochemistry  
  • Mass spectrometry 
  • Nucleic acid assays 
  • Gene testing 
  • HPV molecular diagnostics 

This report delivers timely and actionable intelligence, covering: 

  • Market drivers and major industry trends 
  • New product developments shaping IVD innovation 
  • Competitive landscape insights and activities of key players 
  • Emerging opportunities and strategic growth areas 

With a commitment to delivering precise and up-to-date market intelligence, Kalorama Information continues to provide industry stakeholders with critical data and expert analysis to navigate the ever-evolving IVD landscape. 

 

Table: Global In Vitro Diagnostic Market, by Segment, YoY Growth, 2023-2024 (%)

Global IVD Market  2023-2024  
YoY % 
Clinical Chemistry  XX% 
Immunoassays – non isotopic   
Infectious disease  XX% 
Other immunos  XX% 
Blood bank screening  XX% 
Drugs of Abuse  XX% 
Diabetes HbA1c, lab  XX% 
Hematology – Core Lab  XX% 
Microbiology (ID/AST)  XX% 
Microbiology (molecular)  XX% 
Coagulation (PT/INR)  XX% 
Histology/cytology  XX% 
d-dimer  XX% 
Nucleic acid assays/genetic tests  XX% 
Blood grouping/typing  XX% 
Blood bank molecular – NAT Screens  XX% 
POC, OTC diabetes  XX% 
POC, OTC other  XX% 
POC, professional/hospital  XX% 
IVD Total  XX% 

Re-evaluated March 2024  

Source: Kalorama Information

For further details and to purchase directly, please contact us

Table of Contents

Chapter 1: Worldwide IVD Market Update – April 2025

IVD Market Demand and Growth

  • Figure 1-1: Segment Performance Commentary, Q1-Q4 2024
  • Table 1-1: Global In Vitro Diagnostic Sales, by Product Market, 2024 ($ million) [Blood bank molecular – NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology – Core Lab, Histology/cytology, HPV, molecular, Immunoassays – non-isotopic (Immuno – Infectious disease, Other immune, Immuno – Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology – Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]
  • Figure 1-2: Quarterly IVD Segment Performance, by Segment, Q1 2024 – Q4 2024 ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other]
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2024 ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other]

COVID-19 Diagnostic Markets

  • Table 1-2: COVID-19 Product Sales, 2024 ($ million) [Immunoassay (Antigen, Serology), Molecular, Rapid]

Effect of COVID-19 on Market Segments

  • Table 1-3: IVD Market Excluding and with COVID-19, 2024 ($ million)
  • Figure 1-4: IVD Market Distribution, by Segment, 2024 (%) [IVD Market Excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments]
  • Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, 2024 ($ million) [IVD Market Excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments]
  • Table 1-4: Global In Vitro Diagnostic Market, YoY Growth 2023-2024 (%) [Blood bank molecular – NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology – Core Lab, Histology/cytology, HPV, molecular, Immunoassays – non-isotopic (Immuno – Infectious disease, Other immune, Immuno – Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology – Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]
  • Figure 1-6: Global In Vitro Diagnostic Market – YoY Growth 2023-2024 (%) [Blood bank molecular – NAT Screens, Blood grouping/typing, Circulating tumor cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, molecular, D-dimer, Hematology – Core Lab, Histology/cytology, HPV, molecular, Immunoassays – non-isotopic (Immuno – Infectious disease, Other immune, Immuno – Blood bank screening, Drugs of Abuse, Diabetes HbA1c, lab), Mass Spectrometry, Microbiology (ID/AST), Microbiology (molecular), Microbiology – Mass Spectrometry, Nucleic acid assays/genetic tests, Other (transplant testing, other, etc.), POC, OTC diabetes, POC, OTC other, POC, professional/hospital]

Chapter 2: Product Trends and New Developments

Liquid Biopsy

Mass Spectrometry

Immunoassay

Molecular

Personalized Medicine

POC

Sequencing

Antigen/Antibody

Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates

  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2023-2024 (%) [Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Dexcom, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific]
  • Figure 3-2: IVD Sales Changes in Market Distribution, 2021-2024 – Roche and Abbott Battle for #1 Spot (%) [Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Dexcom, Exact Sciences, Hologic, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Werfen, Others]
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2022-2024 ($ million)

Q4 2024, Q1 2025 M&A Activity

  • Table 3-1: Q4 2024, Q1 2025 Merger and Acquisition Activity

Abbott Laboratories

  • Table 3-2: Abbott Corporate Summary

Becton Dickinson and Co

  • Table 3-3: Becton Dickinson Corporate Summary

bioMérieux SA

  • Table 3-4: bioMérieux Corporate Summary

Danaher Corporation

  • Table 3-5: Danaher Corporation Summary

Dexcom, Inc

  • Table 3-6: Dexcom Corporate Summary

Exact Sciences

  • Table 3-7: Exact Sciences Corporate Summary

QuidelOrtho Corporation

  • Table 3-8: QuidelOrtho Corporate Summary

Roche Diagnostic

  • Table 3-9: Roche Diagnostic Corporate Summary

Siemens Healthineers

  • Table 3-10: Siemens Healthineers Corporate Summary

Sysmex Corporation

  • Table 3-11: Sysmex Corporate Summary

Thermo Fisher Scientific

  • Table 3-12: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

Staffing Shortages

LDT Update

IVDR Compliance Deadline Approaches

  • Table 4-1: IVDR New Risk-based Classification System

Telemedicine

Our Knowledge Center provides access to

all market reports